Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe timing of your Mounjaro injection — morning or night — does not affect how well it works. Tirzepatide has a half-life of roughly five days, so it stays active in your system throughout the week regardless of when your weekly dose lands. That said, the time of day you choose matters for one practical reason: managing side effects. Most people starting Mounjaro, or stepping up to a higher strength, notice nausea or fatigue in the day or two after an injection. Choosing your injection time so those first hours fall during sleep is the most common strategy. Mounjaro is a prescription-only medicine assessed and prescribed by a GPhC-registered clinician; your prescriber can advise on the approach that suits your routine and any symptoms you experience.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether switching injection time will improve results or speed things up. It won't, and that's reassuring rather than disappointing. Tirzepatide is absorbed slowly after a subcutaneous injection, reaches peak concentration around 24–72 hours later, and remains in your system for the best part of five days. By the time you inject dose two, dose one is still doing its job. This is quite different from, say, a daily tablet where the timing of each dose shapes the day's drug exposure directly.
What the clock does influence is when you experience any side effects from the injection. Nausea, mild fatigue, or a change in appetite are most likely in the first 24 hours. That window is the main variable you can move by choosing morning versus evening. The Mounjaro injection itself (technique, site rotation, and preparation) matters more to tolerability than the hour on the clock, but timing gives you a useful lever.
The NHS patient information for tirzepatide notes you can inject on any day, at any time of day, with or without food. That flexibility is intentional: the medicine is designed to fit your life, not the other way around.
If you find the 12–24 hours after each dose the toughest, evening injections are worth trying. Inject after your evening meal (or at bedtime if you prefer) and the peak discomfort period runs while you sleep. Many people wake the next morning with only mild residual nausea, which fades over the day. This approach is especially common in the early weeks on 2.5mg and when stepping up.
Morning injections work better for some people. If you wake feeling queasy after an evening dose, or find that lying down makes nausea feel worse, injecting after breakfast can help. You're upright, moving, and more able to sip water and eat lightly through the day. Some people also report that injecting when they feel alert means they stay more mindful of technique (slower injection speed, proper site rotation) which reduces injection-site discomfort.
There's no universally 'right' answer. The approach is to try one time consistently for a few weeks, note how you feel in the days that follow, and adjust if needed. If you want a fuller breakdown of how day and time interact with the weekly schedule, our guide on when you should inject Mounjaro covers the practicalities in detail. Your prescriber is there to help you interpret patterns. Where you inject (abdomen, thigh, or upper arm) is the other comfort variable worth thinking about alongside timing.
Consistency trumps precision here. Mounjaro's dosing schedule is once weekly, and you can choose any day. Once you pick one, stick to it. You can shift your injection day by a day or two if life genuinely requires it (your Patient Information Leaflet explains the minimum gap to observe) but frequent day-hopping isn't ideal for building a reliable routine or understanding what side effects belong to which dose.
Simple anchors help. Some people link their weekly injection to something they already do on that day: Sunday evening after dinner, Monday morning before leaving for work, Friday night when the week is done. A phone reminder for the first three or four weeks prevents accidental missed doses, which are worth avoiding given the titration schedule. If you do miss a dose, refer to the leaflet and your prescriber, do not double up.
Storage is part of the routine too. If you are wondering whether you should keep Mounjaro in the fridge, the short answer is yes, between 2°C and 8°C, so most people take the pen out 15–20 minutes before injecting to let it reach room temperature, which can reduce injection-site stinging. That brief wait fits naturally into a morning or evening habit.
If nausea or fatigue at any point in the week is significantly disrupting your life, don't silently adjust and hope it passes. That's useful clinical information. A prescriber can consider whether a slower titration pace, an anti-nausea strategy, or a timing shift might help, but only if they know what's happening.
At nume, every repeat order goes through a same-day clinical review before dispatch. That review is the right moment to flag symptom patterns, including injection-timing questions. It's also worth knowing that side effects can be reported directly to the MHRA using the Yellow Card scheme, the UK's safety reporting system for medicines. If you have general questions between orders, the FAQs and our aftercare team are available seven days a week. And if you're still considering whether Mounjaro fits your situation, the weight-loss treatment overview sets out how the different options compare.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.